|
NINL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.899700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.239800E-02 |
| Normal-vs-Stage2 |
4.055600E-02 |
| Normal-vs-Stage3 |
2.722000E-03 |
| Normal-vs-Stage4 |
5.068100E-02 |
| Stage1-vs-Stage2 |
3.895600E-01 |
| Stage1-vs-Stage3 |
2.464400E-02 |
| Stage1-vs-Stage4 |
6.093500E-02 |
| Stage2-vs-Stage3 |
4.082400E-01 |
| Stage2-vs-Stage4 |
3.631400E-01 |
| Stage3-vs-Stage4 |
7.842800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.464300E-03 |
| Normal-vs-AfricanAmerican |
5.224100E-02 |
| Normal-vs-Asian |
1.201980E-01 |
| Caucasian-vs-AfricanAmerican |
9.109000E-01 |
| Caucasian-vs-Asian |
1.205370E-01 |
| AfricanAmerican-vs-Asian |
9.012200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.540400E-03 |
| Normal-vs-Female |
3.942200E-03 |
| Male-vs-Female |
4.393800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.675500E-03 |
| Normal-vs-Extreme_Weight |
2.301500E-03 |
| Normal-vs-Obese |
2.436400E-02 |
| Normal-vs-Extreme_Obese |
7.487000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.618800E-01 |
| Normal_Weight-vs-Obese |
6.435800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.548200E-02 |
| Extreme_Weight-vs-Obese |
6.222000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.575500E-02 |
| Obese-vs-Extreme_Obese |
1.463980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.268300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.754010E-02 |
| Normal-vs-Age(61-80Yrs) |
1.006290E-02 |
| Normal-vs-Age(81-100Yrs) |
7.940600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.222600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.382000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.224000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.226000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.166800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.990800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.768400E-02 |
| Normal-VS-Type2 PRCC |
3.001800E-04 |
| Normal-VS-KIRP CIMP |
<1E-12 |
| Normal-VS-Unclassified PRCC |
8.152000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.436500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.62458935193399E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.200000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.62581059726108E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.559600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.27697852292386E-12 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.719700E-03 |
| Normal-vs-N1 |
4.762300E-03 |
| Normal-vs-N2 |
8.17750000000617E-05 |
| N0-vs-N1 |
2.131800E-01 |
| N0-vs-N2 |
3.528200E-02 |
| N1-vs-N2 |
2.571800E-01 |
|
|
